Psychoeducational Strategies During Outpatient Transition to Extended-Release Naltrexone for Patients With Opioid Use Disorder

被引:2
|
作者
Zavod, Abigail [1 ]
Akerman, Sarah C. [1 ]
Snow, Martha M. [2 ]
Tierney, Matt [3 ]
Sullivan, Maria A. [1 ,4 ]
机构
[1] Alkermes Inc, 852 Winter St, Waltham, MA 02451 USA
[2] New Mexico Vet Affairs Med Ctr, Albuquerque, NM USA
[3] Univ Calif San Francisco, San Francisco, CA 94143 USA
[4] Columbia Univ, New York, NY USA
关键词
medication adherence; psychoeducation; opioid withdrawal; BUPRENORPHINE-NALOXONE; DEPENDENCE; MANAGEMENT; METHADONE; THERAPY; CARE; MULTICENTER; ABUSE; XBOT;
D O I
10.1177/1078390318820124
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
BACKGROUND: The United States is experiencing an opioid epidemic. Better approaches to encourage outpatient utilization of Food and Drug Administration-approved medications for the treatment of opioid use disorder, including extended-release naltrexone (XR-NTX), are needed. Withdrawal management before initiation of XR-NTX is challenging for clinicians and patients and represents a major barrier to treatment. AIMS: To review psychoeducational strategies that support patients during outpatient withdrawal management and transition to XR-NTX. METHOD: We reviewed the literature on psychoeducational strategies used during opioid withdrawal management and described the role that nurses can play in facilitating transition to XR-NTX in a Phase 3, placebo-controlled, outpatient trial comparing induction regimens. RESULTS: Supportive interventions include general psychoeducation on addiction, overcoming ambivalence, treatment adherence, anticipating XR-NTX induction, managing psychological and physiological aspects of opioid withdrawal, risks of opioid use, and sources of support during recovery. CONCLUSIONS: Psychoeducational strategies led by nurses can promote treatment adherence during withdrawal management and induction onto XR-NTX.
引用
收藏
页码:272 / 279
页数:8
相关论文
共 50 条
  • [1] Outpatient Transition to Extended-release Naltrexone in Patients With Opioid-use Disorder
    Sullivan, Maria
    Mannelli, Paolo
    Yu, Miao
    Nangia, Narinder
    Graham, Christine
    Webster, Irena
    Tompkins, D. Andrew
    Kosten, Thomas
    Akerman, Sarah
    Silverman, Bernard
    AMERICAN JOURNAL ON ADDICTIONS, 2018, 27 (04): : 323 - 323
  • [2] Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trial
    Bisaga, Adam
    Mannelli, Paolo
    Yu, Miao
    Nangia, Narinder
    Graham, Christine E.
    Tompkins, D. Andrew
    Kosten, Thomas R.
    Akerman, Sarah C.
    Silverman, Bernard L.
    Sullivan, Maria A.
    DRUG AND ALCOHOL DEPENDENCE, 2018, 187 : 171 - 178
  • [3] Extended-release naltrexone for youth with opioid use disorder
    Mitchell, Shannon Gwin
    Monico, Laura B.
    Gryczynski, Jan
    Fishman, Marc J.
    O'Grady, Kevin E.
    Schwartz, Robert P.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2021, 130
  • [4] Extended-release naltrexone for opioid use disorder started during or following incarceration
    Lincoln, Thomas
    Johnson, Benjamin D.
    McCarthy, Patrick
    Alexander, Ellen
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2018, 85 : 97 - 100
  • [5] Injectable Extended-Release Naltrexone Effective for Opioid Use Disorder
    Slawson, David C.
    AMERICAN FAMILY PHYSICIAN, 2018, 97 (12) : 819 - 819
  • [6] Extended-release injectable naltrexone for opioid use disorder: a systematic review
    Jarvis, Brantley P.
    Holtyn, August F.
    Subramaniam, Shrinidhi
    Tompkins, D. Andrew
    Oga, Emmanuel A.
    Bigelow, George E.
    Silverman, Kenneth
    ADDICTION, 2018, 113 (07) : 1188 - 1209
  • [7] Personal recovery among people with opioid use disorder during treatment with extended-release naltrexone
    Marciuch, Anne
    Birkeland, Bente
    Benth, Jurate Saltyte
    Solli, Kristin Klemmetsby
    Tanum, Lars
    Mathisen, Ida
    Weimand, Bente
    HELIYON, 2023, 9 (07)
  • [8] Reduced cigarette smoking during injectable extended-release naltrexone treatment for opioid use disorder
    Wang An-Li
    Shi Zhenhao
    Elman, Igor
    Langleben, Daniel D.
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2020, 46 (04): : 472 - 477
  • [9] Transition of Patients with Opioid Use Disorder from Buprenorphine to Extended-Release Naltrexone: A Randomized Clinical Trial Assessing Two Transition Regimens
    Comer, Sandra D.
    Mannelli, Paolo
    Alam, Danesh
    Douaihy, Antoine
    Nangia, Narinder
    Akerman, Sarah C.
    Zavod, Abigail
    Silverman, Bernard L.
    Sullivan, Maria A.
    AMERICAN JOURNAL ON ADDICTIONS, 2020, 29 (04): : 313 - 322
  • [10] DETERMINANTS OF AN EFFICIENT MODEL OF EXTENDED-RELEASE NALTREXONE INITIATION FOR THE TREATMENT OF OPIOID USE DISORDER
    Murphy, S.
    McCollister, K. E.
    Jeng, P.
    Leff, J.
    Lee, J. D.
    Nunes, E., V
    Novo, P.
    Rotrosen, J.
    Schackman, B. R.
    VALUE IN HEALTH, 2019, 22 : S175 - S175